Caris Life Sciences (CAI) Other Working Capital Changes (2024 - 2026)

Caris Life Sciences' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 162.91% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $9.2 million (changed N/A YoY), while the FY2025 annual figure was $5.1 million, up 265.77% from the prior year.
• Other Working Capital Changes was $1.6 million for Q1 2026 at Caris Life Sciences, up from $345000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.7 million in Q2 2025 to a low of -$2.5 million in Q1 2025.
• Historically, Other Working Capital Changes has averaged $961285.7 across 3 years, with a median of $793000.0 in 2024.
• Biggest YoY gain for Other Working Capital Changes was 220.3% in 2025; the steepest drop was 144.92% in 2025.
• A 3-year view of Other Working Capital Changes shows it stood at -$768000.0 in 2024, then jumped by 144.92% to $345000.0 in 2025, then soared by 350.43% to $1.6 million in 2026.
• The last three Other Working Capital Changes figures came in at $1.6 million (Q1 2026), $345000.0 (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.